Mike Schultz

Mike Schultz possesses extensive experience in the pharmaceutical industry, having held various leadership positions. As Director of National Accounts at Heron Therapeutics, Inc. and Director of Corporate Account Services at Eagle Pharmaceuticals, Inc., Mike Schultz demonstrated expertise in managing corporate partnerships. Prior roles include Regional Business Director at Acacia Pharma, Inc., which was later acquired by Eagle Pharmaceuticals, and District Business Manager at Cadence, acquired by Mallinckrodt. Additionally, Mike Schultz served as Health Science Associate at ARCA biopharma, Inc., showcasing a well-rounded background in business development and account management within the healthcare sector.